drugset / Trial / NCT02651090
Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI
NaSingle-groupOpen-labelDiagnostic
Summary
Patients with renal failure or other reason for contraindication for contrast enhanced computed tomography (CECT) or contrast enhanced magnetic resonance imaging (CEMRI) with suspected liver pathology will be evaluated with Sonazoid enhanced Ultrasound
Timeline
- Start
- 2017-10
- Primary completion
- 2018-03
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perflubutane | Diagnostic / imaging agent | — | Intravenous |
Indications
No indication recorded.